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Background: Silver nanoparticles (AgNPs) are currently one of the most manufactured nanomaterials. A wide range
of toxicity studies have been performed on various AgNPs, but these studies report a high variation in toxicity and
often lack proper particle characterization. The aim of this study was to investigate size- and coating-dependent
toxicity of thoroughly characterized AgNPs following exposure of human lung cells and to explore the mechanisms
of toxicity.
Methods: BEAS-2B cells were exposed to citrate coated AgNPs of different primary particle sizes (10, 40 and 75 nm)
as well as to 10 nm PVP coated and 50 nm uncoated AgNPs. The particle agglomeration in cell medium was
investigated by photon cross correlation spectroscopy (PCCS); cell viability by LDH and Alamar Blue assay; ROS
induction by DCFH-DA assay; genotoxicity by alkaline comet assay and γH2AX foci formation; uptake and intracellular
localization by transmission electron microscopy (TEM); and cellular dose as well as Ag release by atomic absorption
spectroscopy (AAS).
Results: The results showed cytotoxicity only of the 10 nm particles independent of surface coating. In contrast,
all AgNPs tested caused an increase in overall DNA damage after 24 h assessed by the comet assay, suggesting
independent mechanisms for cytotoxicity and DNA damage. However, there was no γH2AX foci formation and no
increased production of intracellular reactive oxygen species (ROS). The reasons for the higher toxicity of the
10 nm particles were explored by investigating particle agglomeration in cell medium, cellular uptake, intracellular
localization and Ag release. Despite different agglomeration patterns, there was no evident difference in the
uptake or intracellular localization of the citrate and PVP coated AgNPs. However, the 10 nm particles released
significantly more Ag compared with all other AgNPs (approx. 24 wt% vs. 4–7 wt%) following 24 h in cell medium.
The released fraction in cell medium did not induce any cytotoxicity, thus implying that intracellular Ag release
was responsible for the toxicity.
Conclusions: This study shows that small AgNPs (10 nm) are cytotoxic for human lung cells and that the toxicity
observed is associated with the rate of intracellular Ag release, a ‘Trojan horse’ effect.
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The past decades have witnessed increasingly rapid ad-
vances in the field of nanotechnology with the production
of numerous engineered nanoparticles that bear outstand-
ing optical, magnetic, catalytic and electrical properties
[1]. Silver nanoparticles (AgNPs) are, largely due to their
antimicrobial properties, the most commonly used engi-
neered nanoparticles in commercialized products [2]. Ap-
proximately 320 tons of AgNPs are manufactured each
year [3]. They are used in nanomedical devices, consumer
products such as cosmetics, clothing, household products,
room sprays and even in food products. Recently, AgNPs
have gained attention for medical imaging and biosensing
purposes [4,5]. However, human exposure is not new and
AgNPs have a history of more than 100 years of use [3].
Inevitably, from the rapid increase in its manufacture and
utilization follows an increased human (and environmen-
tal) exposure, whereas the potential toxicity has yet to be
fully addressed.
The in vitro toxicity of AgNPs has been evaluated in a
wide range of studies but there is still a lack of consistent
and reliable data. This is a general concern in nanotoxicol-
ogy and more research coherence is required for produ-
cing meaningful results [6]. In a recent review, Kim and
Ryu [7] identified increased oxidative stress, apoptosis and
genotoxicity to be the main in vitro outcomes upon
exposure to AgNPs. The major drawback was that the
investigated AgNPs were different in each study; i.e.
manufactured in different ways, more or less purified,
with various size distributions and coatings, tested on
different cell lines under different cell culture condi-
tions, and often without the use of reference materials.
Moreover, there was in general a lack of thorough
characterization of the AgNPs in cell medium. In all,
with contradictory findings reported, there is at present
no general agreement on the in vitro toxicity of AgNPs.
A study by Hackenberg et al. [8] reported reduced cell
viability at a AgNP dose of 10 μg/mL (1 h exposure,
AgNPs <50nm) in human mesenchymal stem cells,
whereas Samberg et al. [9] showed no toxicity for progeni-
tor human adipose-derived stem cells up to 100 μg/mL
(10 and 20 nm AgNPs for 24 h, and then differentiated for
14 days). Also, the stability and aging of AgNPs have been
reported to be important for the toxicological outcome.
Kittler et al. [10] showed a significant increase in toxicity
following storage of AgNPs (in water) up to 6 months
and this was correlated with the release of Ag ions. Ul-
timately, the synthesis method and the presence of re-
sidual contaminants could also account for the observed
toxicity [11].
In addition to reported variations in cytotoxicity, there
is a lack of consensus on the underlying mechanisms
that drive the toxicity of AgNPs: the particles per se,
the released Ag ionic species, or their combination. Forexample, Beer et al. [12] suggested that the cytotoxic
effects of AgNPs, following exposure of A549 cells, were
largely explained by released Ag ions. In a follow up
study, the global gene expression profiling in the same
cell line suggested that even though the responses to Ag
ions and AgNPs were related as regards effects such as
induction of metallothioneins, the AgNPs ultimately af-
fected the cells in a more complex way (for instance by
influencing expression of genes coding for cell cycle pro-
teins) [13]. We recently showed that the cellular uptake
of Ag was significantly higher when cells (A549 and
BEAS-2B) were exposed to Ag as NPs rather than ions
[14]. Thus, there is emerging evidence for the ‘Trojan
horse’ hypothesis according to which the particle medi-
ates the AgNPs uptake via endocytosis thereby increas-
ing the intracellular bioavailability of Ag. Some previous
studies have focused on investigating size dependent ef-
fects of AgNPs. However, whereas for example Liu et al.
[15] reported that 5 nm AgNPs were more toxic compared
with particles sized 20 and 50 nm, respectively, in four dif-
ferent cell lines (A549, HepG2, MCF-7 and CGC-7901),
Kim et al. [16] showed an enhanced release of LDH in the
presence of 100 nm sized AgNPs and reduced cell viability
when compared to smaller sized particles (10 and 50 nm).
In all, few studies exist in which size dependent effects
and underlying mechanisms have been investigated using
properly characterized AgNPs. The aim of this study was
to investigate the toxicity of a panel of highly purified and
well-characterized AgNPs with a specific focus on size-
and coating-dependent effects, and to explore the mecha-
nisms of toxicity. To this end, we used the BEAS-2B cell
line, normal human bronchial epithelial cells (SV-40 im-
mortalized) that are often used as a lung cell model.
Results
Characterization of a panel of AgNPs
NPs from commercial sources were evaluated for their
primary size by TEM and for their agglomeration in cell
medium by photon cross correlation spectroscopy (PCCS)
and ultraviolet–visible (UV–vis) spectroscopy. Representa-
tive TEM pictures of the AgNPs are shown in Figure 1A.
The TEM images of the coated AgNPs dispersed in water
confirmed the primary particle size stated by the manufac-
turers. The uncoated particles had a heterogeneous distri-
bution within the range of 40 to 200 nm, most of them
being around 50 nm.
Changes in hydrodynamic size distribution and state
of agglomeration of all AgNPs monitored directly after
dispersion (0 h) and after 4 h as well as 24 h in cell
medium (BEGM) are presented as density distribution
(by volume) with size in Figure 1B together with the
changes in scattered light intensities for the correspond-
ing time points. The particle size distribution by volume
(d0.1, d0.5, d0.9) is included as an Additional file 1: Table S1.
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Figure 1 (See legend on next page.)
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Figure 1 AgNPs characterization by TEM (A), PCCS (B) and UV–vis (C). TEM images of the AgNPs confirmed the primary size stated by the
manufacturers (A). The hydrodynamic size distribution was performed in cell medium (BEGM) using PCCS. Data is presented as density
distribution by volume together with the corresponding scattered light intensity (B). All the AgNPs agglomerated in cell medium as seen by the
size and position of the density distribution peaks. All but the 10 nm PVP coated AgNPs sedimented significantly over time as indicated by the
reduction of the scattered light intensity. The UV–vis spectra of the 10 nm citrate (C right) and 10 nm PVP (C left) coated AgNPs indicated
particle sedimentation over time as seen from the 400 nm peak reduction.
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intensity of the scattered light increases non-linearly with
increasing particle size, and that two processes hence
occur simultaneously, agglomeration (increased intensity)
and sedimentation (reduced intensity). Furthermore, there
is a risk of overestimation of the proportion of small parti-
cles in the size distributions curves due to rotational diffu-
sion that can take place for non-spherical particles and
give rise to a peak at small particle sizes (<10 nm) [17].
The results showed that particle agglomeration as well as
sedimentation, indicated by a reduction of the scattered
light, was evident for all AgNPs with time but there was a
clear difference between the citrate and PVP coatings. The
10 nm citrate coated AgNPs initially showed a trimodal
size distribution, with peaks centered approximately at 10,
100 and 1000 nm. The two larger modes refer to agglom-
erates, also seen from the TEM investigation, and are ex-
pected due to the high ionic strength in the cell medium
[18]. The peak at 10 nm refers both to particles of this size
and to the rotational diffusion effect, as described above.
After 4 h, the two larger modes were shifted towards lar-
ger sizes indicating further agglomeration. However, after
24 h the size distribution was similar as the initial observa-
tions with smaller size particle/agglomerate distributions.
An evident reduction in scattered light intensity with time
indicates fewer particles in solution and thus, the discrep-
ancy between 4 h and 24 h is predominantly explained by
sedimentation of the largest particles from which follows a
reduced intensity and reduced size distribution of particles
still in solution. The 10 nm citrate coated AgNPs agglom-
erated directly after dispersion (0 h), were less stable with
time in cell medium, and sedimented to a larger extent
when compared with the 10 nm PVP coated AgNPs. The
latter particles showed mostly small particles (<10 nm)
even after 24 h, and only a low amount of agglomerates of
larger sizes. Also the scattered light intensity was relatively
stable with time, indicating a higher stability. The ob-
served differences in agglomeration and sedimentation be-
havior of the citrate and PVP coated 10 nm particles were
further confirmed by UV–vis measurements (Figure 1C),
showing a reduced absorbance with time for the citrate
and PVP coated particles due to sedimentation. The rate
of sedimentation was higher for the citrate coated particles
as compared to the PVP coated AgNPs, in agreement with
the PCCS findings. Also there was a slight broadening ofthe peaks with time, explained by the formation of larger
agglomerates [19].
The freshly prepared 40 nm citrate coated AgNPs had
a trimodal size distribution, with the peaks broadening
out with time up to 4 h. The proportion of the peak of
the largest agglomerates (1000–10000 nm) was reduced
and vanished after 24 h. Similar to findings for the 10 nm
citrate coated particles, the intensity of the scattered light
was reduced at the same time as the size distribution be-
came bimodal and more narrow again due to further ag-
glomeration of the smallest particles and sedimentation of
the larger agglomerates. The 75 nm citrate coated AgNPs
initially showed a trimodal distribution and an increased
agglomeration with time. After 24 h the larger agglomer-
ates sedimented and the smaller particles became more
agglomerated. The uncoated AgNPs also agglomerated
with time but, after 24 h there were no large agglomerates
(>200 nm) in solution. This might be explained by a
higher rate of agglomeration for the uncoated particles,
resulting in large agglomerates that due to sedimentation
were not detected. The observed presence of particles
sized less than <10 nm has been verified for the same
batch of AgNPs elsewhere [20].10 nm AgNPs are cytotoxic for human lung cells
Cytotoxicity of AgNPs was evaluated using two different
assays: Alamar Blue (AB) and Lactate dehydrogenase
(LDH) assays. The AB assay was used to assess cell viabil-
ity and cell proliferation and is based on the reduction po-
tential of metabolically active cells. The read out gives
indications on overall mitochondrial activity after short
exposure time periods (4 h) and is also a measure of cell
proliferation at longer exposure times that allow for cell
division (24 h). BEAS-2B cells were exposed to AgNPs of
different doses (5–50 μg/mL) for 4 and 24 h. After 4 h, no
significant signs of toxicity were observed for any of the
AgNPs up to the highest dose tested (Additional file 2:
Figure S1). Significant cell toxicity was only evident for the
10 nm citrate coated (p ≤ 0.05) and the 10 nm PVP coated
(p ≤ 0.01) AgNPs after 24 h for their highest doses (20 and
50 μg/mL). No significant alterations of the mitochondrial
activity of the BEAS-2B cells were observed for any of
the lower doses (5 and 10 μg/mL) or the other AgNPs
(Figure 2A). The interference of the AgNPs with the AB
AB
Figure 2 Cell viability of BEAS-2B cells after exposure to AgNPs. Cell viability of BEAS-2B cells after 24 h exposure to AgNPs (5–50 μg/mL)
was assessed using Alamar Blue assay (A) and LDH assay (B). Results are expressed as % mitochondrial activity for the Alamar Blue assay and %
membrane integrity for the LDH assay. Results are presented as mean ± standard deviation of 3 independent experiments. Significant results as
compared to the control are marked with asterisks (* for P-value < 0.05, ** for P-value < 0.01, *** for P-value < 0.001).
Gliga et al. Particle and Fibre Toxicology 2014, 11:11 Page 5 of 17
http://www.particleandfibretoxicology.com/content/11/1/11assay was tested in an acellular system and found to be
non-significant (Additional file 3: Figure S2).
The LDH assay is a cytotoxicity assay that measures
membrane damage by quantifying the amount of LDH
released from the cytoplasm. BEAS-2B cells were exposed
to AgNPs (5–50 μg/mL) for 4 and 24 h. No significant
toxicity was observed after 4 h for any of the AgNPs
(Additional file 2: Figure S1). However, significant tox-
icity was observed after 24 h for the 10 nm citrate
coated (p ≤ 0.05) and the 10 nm PVP coated (p ≤ 0.0001)
AgNPs at the highest dose (50 μg/mL). None of the lar-
ger sized AgNPs altered the cell viability (Figure 2B).
Some AgNPs have been shown to interact with the
LDH assay via enzyme inhibition or binding [21,22]. To
investigate this issue we incubated AgNPs with cell ly-
sates and detected the LDH activity after 0, 4 and 24 h
(Additional file 3: Figure S3). The reduction in enzyme
activity was most pronounced for the 10 nm AgNPs,
especially for the citrate coated particles, and occurred
in a time and dose dependent manner. The enzymeinhibition is likely correlated with the Ag release since
Ag ions have been shown to inhibit the catalytic activity
of LDH enzyme [23]. Therefore, LDH results should be
interpreted with caution and the possibility of false nega-
tive results be considered (as a results of enzyme inhib-
ition in the analyzed supernatant), especially for particles
with low stability that release Ag ions.
AgNPs induce DNA damage in human lung cells
The potential of AgNPs to induce DNA damage was in-
vestigated with two different assays: alkaline comet assay
that gives indication on the overall DNA damage (DNA
strand breaks and alkali labile sites) and γH2AX foci for-
mation, which is mainly a marker of DNA double strand
breaks.
The alkaline comet assay was used to determine the
DNA damage associated with exposure to non-cytotoxic
concentrations (10 μg/mL) of AgNPs in BEAS-2B cells.
No significant increase in the percentage of DNA in the
comet tail was observed after 4 h exposure to any of the
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increase in overall DNA damage was observed after 24 h
for all AgNPs, independent of size and coating (Figure 3B).
The γH2AX foci formation was assessed by immuno-
cytochemistry in BEAS-2B cells under the same condi-
tions as for the comet assay, i.e. 4 and 24 h exposure to
10 μg/mL AgNPs. All fluorescent stainings were negativeA
B
C
Figure 3 Genotoxicity of AgNPs in BEAS-2B cells. Comet assay was per
DNA damage was evaluated after 4 and 24 h incubation with 10 μg/mL Ag
presented as mean ± standard deviation of at least 3 independent experim
asterisks (* for P-value < 0.05, ** for P-value < 0.01). Immunocytochemistry o
for 24 h (C). Cells were treated for 24 h with 10 μg/mL AgNPs (10 nm and
exposure, cells were fixed and stained for γH2AX foci (FITC conjugated anti
blue). Pictures were taken with a confocal laser scanning microscope, 40X,for γH2AX both after 4 h (data not shown) and 24 h.
Fluorescence images are shown in Figure 3C for two of
the investigated particles, 10 nm and 75 nm citrate coated
AgNPs. Etoposide, a topoisomerase inhibitor, was used as
a positive control. The results show that none of the
AgNPs induced DNA double strand breaks in BEAS-2B
cells under given test conditions.formed after 4 h (A) and 24 h (B) exposure to AgNPs. The induction of
NPs. DNA damage was expressed as % DNA in tail. Results are
ents. Significant results as compared to the control are marked with
f γH2AX foci in BEAS-2B cells was performed after exposure to AgNPs
75 nm citrate coated) and etoposide 10 μM (positive control). After
-phospho-histone H2AX-Ser 139 antibody, green) and nucleus (DAPI,
oil objective. Images are representative for 3 independent experiments.
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The kinetics of intracellular ROS formation after expos-
ure of BEAS-2B cells to AgNPs was measured using the
dichlorodihydrofluorescein diacetate (DCFH-DA) assay.
The DCFH-DA probe can detect cytosolic radicals such
as hydroxyl, peroxyl, alkoxyl, nitrate and carbonate, but
is not able to pass organelle membranes [24]. None of
the AgNPs induced any significant ROS increase after
24 h, at doses up to 20 μg/mL (Figure 4). The positive
control, tert-butyl hydroperoxide, induced a 2.8-fold in-
crease compared with unexposed cells. No increased
ROS generation was observed during the first 4 h of
exposure (Additional file 4: Figure S4).
AgNPs are readily taken up by human lung cells via
active mechanisms
We next investigated whether the differences in cytotoxicity
could be explained by differences in cellular uptake or
intracellular localization. Intracellular particle localization
in BEAS-2B cells after exposure to 10 μg/mL AgNPs was
investigated using TEM imaging. After 4 h exposure,
AgNPs were taken up and were localized mainly within
membrane-bound structures. No clear differences were ob-
served between the different AgNPs in terms of uptake or
intracellular localization. The corresponding TEM pictures
are presented in the Additional file 5: Figure S5. After 24 h,
all AgNPs were still mainly confined in membrane-bound
structures (Figure 5). Moreover, cellular morphological
changes suggestive of autophagy were observed for the
10 nm PVP coated AgNPs (Figure 5c). There were no
signs of nuclear localization for any of the particles.
The cellular dose (i.e. cellular uptake as well as AgNPs
tightly attached to the cell membrane) of AgNPs in
BEAS-2B cells was quantified using AAS analysis. These
measurements resulted in an average Ag concentrationFigure 4 ROS levels in BEAS-2B cells after exposure to AgNPs. ROS for
assay. Cells were incubated with AgNPs (5, 10, 20 μg/mL) for 24 h and then
were performed every 5 min over 30 min. Tert-butyl hydroperoxide (TB
as mean slope per min and normalized to the unexposed control. Resu
experiments.per cell in the range of 2.1 – 10 pg after 4 h (Figure 6A).
The results indicated the highest uptake (10 pg/cell) for
the 50 nm uncoated AgNPs. There was no major differ-
ence between the PVP and citrate coated particles and no
obvious size dependent uptake; the 10 nm and 75 nm cit-
rate coated AgNPs showed similar cellular concentrations
(2.9 and 3.2 pg/cell). When the data was converted to per-
centage uptake from the total added Ag the results were
in the range of 3.2 and 12.1%.
The uptake mechanisms were addressed by using
pharmacologic inhibitors of different endocytic pathways
together with experiments performed at 4°C in which
energy dependent uptake is stalled. We selected the
10 nm and 75 nm citrate coated AgNPs to identify a pos-
sible size-dependent difference in the uptake mechanisms.
As shown in Figure 6B, both 10 nm and 75 nm citrate
coated AgNPs were taken up by active mechanisms as evi-
dent by a negligible uptake at 4°C (2.4% and 6.8%). Actin
dependent pathways were involved in the internalization
of both particles as observed by the cytochalasin D in-
hibition (35% uptake for the 10 nm and 51% uptake for
the 75 nm AgNPs). Overall the uptake was a combin-
ation of active mechanisms (clathrin, caveolin/lipid raft,
macropinocytosis and phagocytosis) as indicated by the
decreased uptake following treatment with the additional
pharmacological inhibitors (amantadine, nystatin, amiloride
and wortmannin).
Small AgNPs release more Ag in biological medium
The amount of released Ag present in solution (non-pre-
cipitated) from the AgNPs after 4 and 24 h incubation in
cell medium (BEGM) is presented in Figure 7 in relation
to the total amount of added AgNPs (10 μg/mL). The re-
leased amount of Ag in solution increased with time for
all particles. The 10 nm citrate coated AgNPs revealed amation after exposure to AgNPs was investigated using the DCFH-DA
with 20 μM DCF-DA probe for 40 min. Readings (Ex485 nm/Em535 nm)
P, 15 μM) was used as positive control. ROS increase was calculated
lts are presented as mean ± standard deviation of 4 independent
Figure 5 Intracellular localization of AgNPs in BEAS-2B cells. Intracellular localization of AgNPs was investigated by TEM (A-F with
corresponding inserts a-f).TEM images of untreated BEAS-2B cells show no morphological modifications (A, a). After 24 h exposure to 10 μg/mL
10 nm citrate coated (B, b), 10 nm PVP coated (C, c), 40 nm citrate coated (D, d), 75 nm citrate coated (E, e), and 50 nm uncoated (F, f) AgNPs,
particles were taken up and contained mainly within membrane-bound structures (b, d, e, f). Vesicular structures consistent with autophagy were
detected for the 10 nm PVP coated AgNPs (c).
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pared with the 10 nm PVP coated AgNPs (5.8%). This
discrepancy is related to differences in capping agent
stability, as discussed below. However, after 24 h the re-
lease was more similar, 23.6% and 21.5% for the 10 nm
citrate and PVP coated AgNPs, respectively. The 40 nm
and 75 nm citrate coated AgNPs showed a relatively
similar Ag release (3.9% and 2.9% at 4 h; 7% and 6.5%
after 24 h). Overall the 50 nm uncoated AgNPs showed
the lowest released fraction, (1.8% at 4 h and 4.4% at 24 h),
likely related to their lower particle stability and hence a
more rapid formation of larger agglomerates that sedi-
ment. As a result, the exposed surface area will be re-
duced thus slowing down dissolution kinetics. The total
amount of Ag released in solution may, however, be
underestimated due to complexation processes between
released Ag and cell medium components and concomi-
tant precipitation.
We then attempted to mimic the intracellular behav-
ior of AgNPs by investigating the Ag release in ALF
(artificial lysosomal fluid) of pH 4.5. As presented inAdditional file 6: Figure S6, the overall amount of re-
leased Ag present in solution was very low (less than
2%), hence considerably lower than corresponding mea-
surements in cell medium. This is related to the lack of
stability and pronounced sedimentation of AgNPs in
this fluid [25] and complexation of released Ag ionic
species (e.g. AgCl). These findings are in agreement with
a study by Stebounova et al. [25] who measured negli-
gible released quantities of Ag in solution from AgNPs
in two simulated biological fluids, artificial lysosomal
fluid and artificial interstitial fluid.
In order to investigate whether the released Ag ionic
species could account for the observed toxicity, the
BEAS-2B cells were exposed for 24 h to the extracted
“released Ag fraction”, i.e. the supernatants collected
after 24 h incubation of 10 nm citrate and PVP coated
AgNPs dispersions (50 μg/mL) in cell medium (Figure 8).
However, there were no signs of toxicity as indicated by
the AB assay, suggesting that the toxic effects observed
after 24 h were not related to extracellular Ag release in
cell medium.
Figure 7 Quantification of the Ag release in cell medium. The amount of released Ag in cell medium (BEGM) after 4 and 24 h at 37°C was




Figure 6 Uptake of AgNPs by BEAS-2B cells. The cellular Ag dose was quantified by AAS (A). BEAS-2B cells were exposed to 10 μg/mL AgNPs
for 4 h and the total cellular Ag content was analyzed by AAS. The Ag dose was expressed as pg per cell. Results are presented as mean ± standard
deviation of 2 replicates. The uptake mechanisms were investigated using pharmacological inhibitors and 4°C exposure (B). BEAS-2B cells were
pre-incubated with different pharmacological inhibitors at 37°C (clathrin-mediated endocytosis: amantadine 200 μM for 30 min, caveolin/lipid
raft mediated endocytosis: nystatin 25 μM for 30 min, macropinocytosis: amiloride-HCl 100 μM for 30 min, general fluid-phase endocytosis:
wortmannin 400 nM for 30 min, actin-dependent phagocytosis: cytochalasin D 1 μM for 1 h). For energy dependent inhibition of uptake the
cells were pre-incubated at 4°C for 30 min. Following the pre-incubations, cells were exposed to 10 μg/mL 10 nm citrate coated or 75 nm
citrate coated AgNPs for 2 h in the presence of the inhibitors or at 4°C. The total Ag content was determined using AAS. The results are
expressed as % of the corresponding controls and presented as mean ± standard deviation of 2 replicates.









































24 h cell exposure
24 h 37 C
cell medium
Centrifugation
24 h cell exposure to
”released fraction”
Figure 8 Cytotoxicity of the extracellular release Ag fraction. The Ag released fraction in cell medium was obtained by incubating 50 μg/mL
AgNPs in BEGM at 37°C for 24 h. BEAS-2B cells were incubated with the respective supernatants for 24 h and cytotoxicity was measured with the
Alamar Blue assay. Results are presented as mean ± standard deviation of 2 independent experiments.
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The toxicity of AgNPs to eukaryotic cells, bacteria and
multicellular organisms has been investigated in a num-
ber of studies, most of which overlook fundamental
issues. For instance, not all studies indicated whether the
nanoparticles were purified after synthesis or not, and
many studies failed to describe the behavior of nanopar-
ticles in the given biological media [26,27]. The purpose
of this study was to investigate the toxicity of a panel of
highly purified and well-characterized AgNPs with a
specific focus on size- and coating-dependent effects,
and to explore the mechanisms of possible differences
in toxicity.
In the present study we used exposure concentrations
in the range of 5–50 μg/mL, primarily based on previous
studies of Ag nanoparticles and eukaryotic cells [26].
This may be related to a possible human exposure by
using exposure data from a AgNPs manufacturing facility
(maximum level 289 μg/m3 [28]), and by applying the
same assumptions and calculations as in the study by
Wang et al. [29]. A concentration of 10 μg/mL would then
approximately correspond to the total cellular deposition
following 74 working weeks (8 h per day, 5 days per week).
Thus, the doses used should be considered high but likely
possible to be reached following years of exposure, or after
acute accidental exposure.The results showed a clear size dependent toxicity for
the tested AgNPs since only the 10 nm AgNPs were
cytotoxic for the BEAS-2B cells starting at doses of
20 μg/mL in the Alamar Blue assay. There was, however,
no difference in toxicity between the 10 nm citrate and
10 nm PVP coated AgNPs, suggesting that the size rather
than the capping agent was the property that triggered
toxicity. Other studies have also reported higher toxicity
for smaller compared to larger sized AgNPs. For example,
Carlson et al. [30] showed an increased ROS generation
for 15 nm hydrocarbon coated AgNPs as compared to
55 nm, which also correlated with decreased cell viabil-
ity in macrophages. Furthermore, Liu et al. [15] found
that 5 nm AgNPs were more toxic than 20 and 50 nm
AgNPs in four cell lines (A549, HepG2, MCF-7, SGC-
7901). Using the same kind of AgNPs as in the present
study (10 nm PVP coated), George et al. [31] reported
approximately 35% cytotoxicity following exposure of
fish gill cells to doses of 25 μg/mL; thus, a very similar
extent of cytotoxicity as in the present study, and no
cytotoxicity for the 40 nm. Recently also Wang et al.
[29] showed that 20 nm citrate and PVP coated AgNPs
induced more cellular toxicity than larger particles (110 nm)
and furthermore that the citrate coated 20 nm generated
acute neutrophilic inflammation in the lungs of exposed mice
to a much higher extent when compared to the larger ones.
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cells we used the alkaline version of the comet assay and
γH2AX foci induction. In contrast to the size-dependent
effect on cell viability, we found that all tested AgNPs in-
duced DNA damage after 24 h as reported by the comet
assay, but without γH2AX induction. There were, however,
no signs of DNA damage at earlier time points (4 h) sug-
gesting indirect genotoxic mechanisms that take more
time to occur. The effect on cell viability and the DNA
damage may potentially be explained by ROS generation
[32]. However, we could not provide any evidence of intra-
cellular ROS production preceding (geno)toxicity, thus
contradicting many other published in vitro studies [7].
The comet assay is a highly sensitive method and widely
applied in nanotoxicological studies [33], but it gives
limited mechanistic insight. Thus, the more precise
mechanism of genotoxicity warrants further investiga-
tion. One hypothetical explanation for the detected
DNA damage could be the interaction of the particles
with the DNA repair pathways. Such interactions have
been previously reported for AgNPs e.g. reduction of
the formamidopyrimidine DNA glycosylase activity [34]
and down regulation of genes involved in DNA damage
response/repair system (XRCC1 and 3, FEN1, RAD51C,
RPA1) [35].
Next we investigated the mechanisms behind the ob-
served size-dependent cytotoxicity by analysis of the
cellular uptake and uptake mechanisms, intracellular
localization, agglomeration and the released Ag fraction
in cell medium. The TEM images showed that all AgNPs
were mainly localized within membrane-bound structures.
No AgNPs were detected in the cell nuclei, although nu-
clear presence has previously been reported for BEAS-2B
cells (43–260 nm AgNPs) [36], U521 cells (6–20 nm
AgNPs) [37], HaCaT cells (30 nm AgNPs) [38] and hMSC
(AgNPs <50 nm) [8]. Multi-lamellar structures consistent
with autophagy were observed for the 10 nm sized AgNPs.
Induction of autophagy has been reported for several engi-
neered nanoparticles, including AgNPs and Ag nanowires
[37,39], and may represent a common cellular response to
nanoparticles. In general, differences in the intracellular
localization of the particles could not explain observed
differences in toxicity. Moreover, when comparing the
total cellular Ag content, determined by AAS, we could
not detect a higher cellular dose of the most cytotoxic
NPs, the 10 nm particles. Thus, the intracellular dose,
that often is regarded to be of importance for toxicity,
could not explain the higher toxicity of the 10 nm
AgNPs. The total uptake was around 2–4 pg/cell for the
coated and somewhat higher (approx. 10 pg/cell) for the
uncoated AgNPs, in agreement with our previous stud-
ies of cellular uptake of AgNPs in BEAS-2B and A549
cells [14]. Observed findings are also within the same
range as reported in a recent study on HepG2 cells with6.8 pg Ag/cell following exposure to 10 μg/mL AgNPs
for 24 h [40]. Interestingly, the same study further
attempted to distinguish between AgNPs and Ag ions in
the cells by using Triton-X 114-based cloud point ex-
traction of the cell lysates. The authors concluded that
approximately 10% of the total amount of Ag within the
cells existed as Ag ions. Since this value was higher than
the corresponding fraction of Ag ions prior to exposure
(5.2%), they argued that transformation of AgNPs to Ag
ions could have taken place intracellularly.
In the present study we carefully addressed time-
dependent changes in agglomeration, an aspect often
completely overlooked in studies within the field of
nanotoxicology. There are several factors that should be
taken into account when evaluating the agglomeration
of the different particles. For example, it is well known
that the intensity as measured using light scattering
techniques increases with particles size in a non-linear
manner, and at the same time sedimentation reduces
the intensity thus making the interpretation non-trivial.
Clearly, however, there was an evident difference in stabil-
ity between the citrate and PVP coated 10 nm particles.
This could be explained by the more rapid displacement
of the electrostatically weakly bound citrate with medium
components (e.g. aminoacids), triggered by the high ionic
strength of the medium, when compared to the non-
charged larger PVP polymer capping agent. A more rapid
breakdown of the stabilizing coating will evidently affect
the stability of the particles. The lower stability of the cit-
rate coating also resulted in higher Ag release compared
with the PVP coated Ag NPs in cell medium after 4 h.
However, observed differences in agglomeration did not
translate to differences in Ag release or toxicity after 24 h.
This is perfectly in line with the recent study by Wang
et al. [29] showing higher Ag release in BEGM media
from 20 nm citrate coated Ag nanoparticles when com-
pared to PVP coated particles at 6 h, followed by a very
similar release at 24 h. Also, in accordance with our re-
sults, they report higher Ag release and toxicity from
the smaller (20 nm) compared to the larger (110 nm)
Ag nanoparticles. In all, the primary particle size seems
to be more important than the size of the agglomerates
for Ag release [41] and, according to the present study,
for toxicity as well.
Proteins in the cell medium are known to be import-
ant for the stabilization of citrate coated AgNPs via the
formation of a protein corona [42]. Therefore the low
protein content of our working medium (serum free)
could partially explain the agglomeration of the citrate
coated particles upon dispersion. Ultimately the protein
corona may play a role in the cellular uptake. Monteiro-
Riviere et al. [43] recently showed that pre-incubation of
citrate coated Ag nanoparticles with different proteins
(albumin, IgG, transferrin) reduced the cellular uptake
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behavior of the different sized nanoparticles used in this
study together with the low protein content in the
working cell medium, suggest that the protein corona is
unlikely to explain the observed differences in toxicity.
Differences in nanoparticle agglomeration affect sedi-
mentation and may ultimately result in changes in the
exposure doses and uptake rates [44]. However, the up-
take of the 10 nm citrate and 10 nm PVP coated AgNPs
was similar (2.9 pg/cell and 2.1 pg/cell) and in the same
range as the 75 nm citrate coated AgNPs (3.2 pg/cell).
Next we explored the uptake mechanisms for the 10
and 75 nm citrate coated AgNPs and found that both
particles were internalized by active mechanisms as
shown by the negligible uptake at 4°C. A combination
of different active pathways was involved for both parti-
cles as previously shown for AgNPs [45] as well as other
nanomaterials e.g. quantum dots [46]. Thus, while we
acknowledge the importance of agglomeration for particle
stability, and the fact that this, as well as the protein cor-
ona can affect cellular uptake, metal release and toxicity, it
appears not to play a major role in the toxicity observed
for the 10 nm citrate and 10 nm PVP coated particles.
The main difference between the AgNPs in our study
was the released amount of Ag in cell medium, which
was significantly higher for the 10 nm AgNPs. One
explanation for this is obviously the increased surface
area and increased particle number (196 fold increase
for 10 nm vs. 40 nm particles and 1140 fold increase for
10 nm vs. 75 nm particles) for the same mass/volume
dose. This is in line with previous reports showing that
the release of Ag is directly related to the total surface of
the particles as well as the composition of the experimen-
tal media [47]. Ag release has previously been reported to
increase with smaller particle size in a non-linear manner
[48], thus explaining the much higher release from the
10 nm particles when compared to the other sizes. To
further explore the role of the released Ag, we also in-
vestigated the toxicity of the “released fraction” (i.e. the
supernatant of centrifuged particles after incubation in
cell medium for 24 h thus likely containing various
Ag-complexes). However, no effect on cell viability was
observed after incubating BEAS-2B cells with this fraction
and we therefore concluded that the extracellular release
and presence of ionic species in cell medium could not ac-
count for the observed differences in toxicity. We thus
posit that the size dependent toxicity relates to the intra-
cellular release of Ag ions. When we attempted to mimic
one intracellular compartment, the lysosome, by using
artificial lysosomal fluid (ALF), very little release was ob-
served (Additional file 6: Figure S6). This is explained by
the severe agglomeration that takes place in this solution
due to the very high ionic strength [25] since low pH (in
low ionic strength solutions) is known to cause higher Agrelease [48]. In addition, ALF does not contain any pro-
teins that can serve to stabilize the particles and we con-
clude that mimicking various intracellular compartments
is challenging. Previous studies have shown that Ag ions
interfere with cellular functions by interacting with the
thiol and amino groups of biomolecules [26], thus provid-
ing an explanation for the toxicity. Ag release has also
been reported to govern the toxicity of AgNPs towards
bacteria, where the particles act as a vehicle for Ag deliv-
ery [49]. In the same study the antibacterial effect was hin-
dered under anaerobic conditions (that prevent oxidation
and Ag release) [49]. Moreover, AgNPs with higher Ag
release were shown to be more toxic in Caenorhabditis
elegans [50]. In all, this suggests that AgNPs may change
the transport rate of Ag ions into cells and organisms and
that subsequently released Ag ions exert the detrimental
effects.
Conclusion
The present study addresses aspects that often are over-
looked in nanotoxicology studies such as careful time-
dependent characterization of agglomeration and ion
release. The study clearly shows size-dependent cytotox-
icity of AgNPs since only the 10 nm particles affected the
cell viability of human lung cells. Despite differences in ag-
glomeration of the citrate and PVP coated 10 nm particles,
there was no coating-dependent difference in cytotoxicity.
Furthermore, our results suggest that intracellular metal
release rather than differences in cellular uptake or intra-
cellular localization is a likely explanation for the observed
differences in cytotoxicity. This study thus provides sup-
port for the so called ‘Trojan horse’ mechanism by which




Five types of AgNPs were investigated in this study. 10 nm
OECD PVP BioPure™ Silver, 10 nm Citrate BioPure™ Silver,
40 nm Citrate BioPure™ Silver and 75 nm OECD Citrate
BioPure™ Silver were purchased from NanoComposix,
Inc (San Diego, CA) in the form of stock dispersions
(1 mg/mL) in Milli-Q water (for the PVP coated) or aque-
ous 2 mM citrate (for the citrate coated). Uncoated
AgNPs in the form of powder (40–50 nm) were supplied
by EV NANO Technology Co Ltd, China. All particles
were negative for endotoxin contamination in the lim-
ulus amebocyte lysate (LAL) test, performed as described
elsewhere [51].
Nanomaterial physico-chemical characterization
Primary characterization of AgNPs by TEM
TEM images were acquired using a Tecnai 10 apparatus
(Fei, The Netherlands) at an acceleration voltage of 100 kV
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GmbH, Munchen, Germany). The particles were diluted
in Milli-Q water and droplets of 3 μL were placed on
TEM grids for 5 min followed by water removal with filter
paper. TEM images of the uncoated Ag NPs were made
using a JEOL JEM 2100F instrument operating at 200 kV.
Characterization of AgNPs in cell medium by PCCS
The size distribution in cell medium (BEGM) was investi-
gated using dynamic light scattering (DLS) on an instru-
ment employing photon cross correlation spectroscopy,
PCCS (NanoPhox, Sympatec, Germany). 10 μg/mL AgNPs
dispersions were prepared and analyzed directly after
preparation (0 h), after 4 h as well as 24 h while keeping
the cuvette inside the PCCS instrument. Duplicate sam-
ples were investigated to verify the agglomeration trends
but the data presented are based on single samples that
were measured three times at 25°C. Data from the unique
measurements was integrated to produce a single distribu-
tion with the PCCS software (Windox 5). Standard latex
samples (20 ± 2 nm) (Sympatec) and blank samples were
tested prior to analysis to ensure the accuracy of the
measurements. The BEGM medium components re-
sulted in a background contribution (colloids less than
5 nm) that was subtracted from the measured distribu-
tion for all AgNPs.
UV–vis spectra in cell medium
Ultraviolet–visible (UV–vis) absorption spectra of the
AgNPs dispersed in cell medium was determined on
10 μg/mL dispersions of 10 nm citrate and 10 nm PVP
coated AgNPs in cell medium (BEGM) using a Jasco
V-630 UV/VIS-Spectrophotometer. The absorption spec-
tra were recorded immediately after dispersion (0 h) and
after 4 as well as 24 h by keeping the cuvette inside the
instrument.
Preparation of AgNPs dispersions
The dilutions of coated AgNPs dispersions (10 nm OECD
PVP BioPure™ Silver, 10 nm Citrate BioPure™ Silver,
40 nm Citrate BioPure™ Silver and 75 nm OECD Citrate
BioPure™) were performed in complete cell medium prior
to exposure. The 50 nm uncoated AgNPs dispersion was
freshly prepared (1 mg/mL) in cell medium followed by
30 min sonication in a sonication bath on ice. Subse-
quent dilutions were prepared in cell medium prior to
exposure.
Cells and cell culture conditions
The normal bronchial epithelial cell line (BEAS-2B,
European Collection of Cell Cultures) was used in this
study. BEAS-2B cells were cultured in Bronchial epithe-
lial cell growth medium (BEGM™, Lonza) supplemented
with recombinant epidermal growth factor (EGF),hydrocortisone, insulin, bovine pituitary extract, GA-
1000 (Gentamicin Sulfate and Amphotericin-B), retinoic
acid, transferrin, triiodothyronine, epinephrine according
to manufacturers’ instructions. No fetal calf serum was
added in the cell medium. The cells were seeded in flasks
and plates pre-coated with a mixture of 0.01 mg/mL fibro-
nectin, 0.03 mg/mL bovine collagen type I, 0.01 mg/mL
bovine serum albumin and 0.2% penicillin-streptomycin
in BEGM additive free medium. The cells were incu-
bated in a humidified atmosphere at 37°C, 5% CO2 and
sub-cultured at 80% confluency.
For each experiment, BEAS-2B cells were seeded one
day prior to AgNPs exposure, at an approximate density of
3 × 104 cells/cm2 for 24 h exposure and 6 × 104 cells/cm2
for 4 h exposure in suitable cell culture plates.Cellular uptake of AgNPs
Transmission electron microscopy
BEAS-2B cells were seeded in 6 well plates and exposed
to 10 μg/mL of each of the AgNP dispersions for 4 and
24 h, respectively. After exposure, cells were harvested
and fixed in freshly prepared 0.1M glutaraldehyde solu-
tion, rinsed in phosphate buffer (PB) and centrifuged.
The pellets were then post fixed in 2% osmium tetroxide
in 0.1 M PB, pH 7.4 at 4°C for 2 h, dehydrated in ethanol
followed by acetone, and embedded in LX-112 (Ladd,
Burlington, Vermont, USA). Ultrathin sections (approxi-
mately 60–80 nm) were cut by a Leica ultracut UCT
(Leica, Wien, Austria) and contrasted with uranyl acetate
followed by lead citrate and examined with in Tecnai 12
Spirit Bio TWIN transmission electron microscope (Fei
company, Eindhoven, The Netherlands) at 100 kV. Digital
images were captured by using a Veleta camera (Olympus
Soft Imaging Solutions, GmbH, Münster, Germany).Atomic absorption spectroscopy
BEAS-2B cells were seeded in 24 well plates and exposed
to 10 μg/mL of each of the AgNP dispersions, in dupli-
cates, for 4 h. After exposure the cells were thoroughly
washed, harvested and counted. The total Ag concentra-
tion in solution was determined using AAS in the graphite
furnace mode (Perkin Elmer Analyst 800). Calibration
standards at 7.5, 15, 30, 45 μg Ag/L were prepared from a
1 g/L standard from Perkin Elmer. The calibrations curve
was linear up to approx. 35 μg/L. The samples were first
acidified to a pH <2 with 65% HNO3 (puriss p.a.),
followed by digestion (1 mL sample + 1 mL 30 wt%
H2O2 (Fluka, puriss p.a.), 3 mL 65 wt% HNO3 (Sigma,
Suprapur, 100 μL 30 wt% HCl (Fluka, trace select) via
UV treatment (Metrohm 705 UV digestor, 95°C for 2 h).
As noted, 100 μL HCl was typically added as well to the
digestion. This amount was, however, varied at times to
confirm that all Ag was available in the form of aqueous
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amount of Ag in the samples was measured using AAS.
This was verified by analyzing digested samples spiked
with known amounts of AgNPs. These samples yielded
acceptable recoveries of the spiked Ag amount (±15%
deviations). The determination limit was estimated to
5 μg/L. Triplicate readings were analyzed for each sample
and control samples of known Ag concentration were ana-
lyzed in parallel generating data with the standard devi-
ation of three independent samples and the blank value
(matrix effect), if >0, subtracted. Results were expressed as
the mean amount of Ag in pg/cell.
Uptake mechanisms using endocytosis inhibitors
BEAS-2B cells were seeded in 6 well plates and pre-
incubated with different pharmacological inhibitors at
37°C (amantadine 200 μM for 30 min, nystatin 25 μM
for 30 min, amiloride-HCl 100 μM for 30 min, wortman-
nin 400 nM for 30 min, cytochalasin D 1 μM for 1 h). The
selection of inhibitors was justified from their ability to se-
lectively inhibit different pathways: amantadine blocks the
clathrin-dependent endocytosis [52], nystatin disrupts
caveolar structure [53], amiloride interferes with macropi-
nocytosis [54], wortmannin reduces fluid-phase endocyto-
sis [55] and cytochlasin D inhibits actin-dependent uptake
[52]. The dose of inhibitors was selected based on pre-
viously published literature. The inhibitors were not cyto-
toxic at the given dose and exposure time (data not
shown). For energy dependent inhibition of uptake, the
cells were pre-incubated at 4°C for 30 min. Following the
pre-incubations, cells were exposed to 10 μg/mL 10 nm
citrate coated or 75 nm citrate coated AgNPs for 2 h in
the presence of the inhibitors or at 4°C. Subsequently the
cells were thoroughly washed with PBS buffer (5 times),
harvested and counted using an automated cell counter
(Biorad TC20). The total Ag content was determined
using AAS according to the above mentioned procedure.
The results were normalized according to the cell number
and expressed as % of the controls (10 μg/mL 10 nm cit-
rate coated or 75 nm citrate coated AgNPs, 2 h, without
inhibitors, 37°C). Results are presented as mean ± standard
deviation of 2 replicates.
Cell viability
Lactate dehydrogenase assay
The LDH assay is used to evaluate the degree of cellular
membrane damage associated with leakage of the cyto-
solic LDH enzyme. The Cytotox 96® Non-Radioactive
Cytotoxicity Assay Kit (Promega) was used in a 96 well
plate format. The cells were exposed to the AgNP dis-
persions at particle doses ranging from 5 to 100 μg/mL
in 100 μL for 4 and 24 h. After exposure, 50 μL of the
supernatant was transferred to a new 96 well plate. Therest of the supernatant was discarded and the cells were
lysed with 100 μL Triton 1% for 30 min at 37°C. 50 μL
of the lysate was transferred to a new 96 well plate and
50 μL of reconstituted substrate was added to both the
supernatant and the cell lysate plates. After 20 min incu-
bation at dark conditions, reactions in both plates were
terminated using 50 μL stop solution. Absorbance was
measured at 495 nm using a plate reader (Tecan Infinite
F200). The absorbance of the supernatant corresponds
to the LDH release, whereas the sum of the absorbance
of the supernatant and cell lysate corresponds to the
maximum LDH release. The cell viability was calculated
by dividing the LDH release to the maximum LDH re-
lease for each well. The control was set to 100% viability
and the results were expressed as percentage cell viabil-
ity. The experiments were performed at least three times
in triplicate wells for each time point and AgNP dose.
The interference of AgNPs with the LDH assay was
tested in an acellular system (to test whether particles
may catalyze the reaction in absence of LDH or interfere
with the absorbance reading), as well as by incubating
cell lysates with AgNPs before performing the assay (in
order to test whether AgNPs may inhibit the LDH enzyme).
The acellular interference was performed by incubating
different concentrations of particles with reconstituted
LDH substrate. The interference was found to be non-
significant. The interference of the AgNPs with the LDH
assay in terms of possible enzyme inhibition was investi-
gated by incubating cell lysates with AgNPs (5 μg/mL and
20 μg/mL) for 0, 4 and 24 h before performing the LDH
assay.
Alamar Blue assay
The AB assay is used to assess cell viability based on the
reduction potential of metabolically active cells. BEAS-2B
cells were seeded in transparent 96 well plates and ex-
posed to the AgNP dispersions at concentrations ran-
ging from 5 to 100 μg/mL for 4 and 24 h. After
exposure, 10 μL of AlamarBlue® reagent (Invitrogen)
was added in each well and incubated for 2 h at 37°C.
The fluorescence was measured at 560 nm excitation
and 590 nm emission wavelengths using a plate reader
(Tecan Infinite F200). Results were expressed as percent-
age cell viability versus the control. The experiments were
performed at least three times in triplicate wells for each
time point and AgNP dose. For the cytotoxicity of the
“released fraction”, BEAS-2B cells were incubated for
24 h with the supernatant of 50 μg/mL dispersions of 10
nm PVP and citrate coated AgNPs in complete cell
medium, kept at 37°C for 24 h. This experiment was
performed twice in triplicate wells. Interference of the
AgNPs with the assay was tested in an acellular system by
incubating different doses of AgNPs (5, 10, 20, 50 μg/mL)
with the AB reagent for 2 h at 37°C in 96 well plates.
Gliga et al. Particle and Fibre Toxicology 2014, 11:11 Page 15 of 17
http://www.particleandfibretoxicology.com/content/11/1/11Detection of ROS production
Intracellular ROS levels were measured using the
dichlorodihydrofluorescein diacetate (DCFH-DA) assay.
DCFH-DA is a lipophilic cell permeable compound that
is deacetylated in the cytoplasm to DCF by cellular ester-
ases. DCF is then oxidized by radicals such as hydroxyl,
peroxyl, alkoxyl, nitrate and carbonate to a fluorescent
molecule (excitation 530 nm, emission 485 nm). DCF is
not oxidized by hydrogen peroxide per se nor superoxide
radical [56]. Karlsson et al. [24] argued that the DCF assay
reflects lysosomal and mitochondrial membrane perme-
abilisation (that involves release of redox-active ions and
cytochrome c that catalyzes the DCF oxidation) as the
DCF accumulates in the cytosol and is unable to pass or-
ganelle membranes. BEAS-2B cells were seeded in black
96 well plates with transparent bottom and incubated with
AgNPs (5, 10, 20 μg/mL) for 24 h. After exposure, cells
were washed with HBSS and loaded with 20 μM DCFH-
DA in HBSS (Hank’s buffered salt solution) for 30 min at
37°C. Thereafter, cells were washed with HBSS and fluores-
cence was recorded every 5 min over 30 min (excitation
485 nm, emission 535 nm) using a plate reader (Tecan In-
finite F200) at 37°C. Tert-butyl hydroperoxide (TBP, 15
μM) was used as positive control. ROS increase was calcu-
lated as mean slope per min and normalized to the unex-
posed control. Results are presented as mean ± standard
deviation of 4 independent experiments.
Genotoxicity
Alkaline single-cell gel electrophoresis (comet assay)
The comet assay is based on the microscopic detection
of damaged DNA fragments of individual cells, appearing
as “comets” upon cell lysis, subsequent DNA denaturation
and electrophoresis. The alkaline version (PH > 13) is
mostly used for the detection of single and double DNA
strand breaks, DNA cross‐links, and alkali labile sites
(ALSs). The comet assay is widely used to investigate gen-
otoxicity of nanomaterials [33]. BEAS-2B cells were
seeded in 24 well plates and exposed to 10 μg/mL AgNPs
dispersions for 4 and 24 h. The dose was selected based
on the cytotoxicity results. Cells were harvested and ap-
proximately 104 cells per exposure were embedded into
0.75% low melting agarose (on 0.3% agarose pre-coated
glass slides) and lysed with a freshly prepared 1% Tri-
ton lysis buffer (pH 10) for 1 h on ice at dark condi-
tions. Alkaline unwinding was performed for 40 min
on ice at dark conditions using 0.3 M NaOH (pH > 13)
followed by DNA electrophoresis in the same alkaline
solution for 30 min at 29 V. The slides were neutralized in
0.4 Tris Buffer for 5 min twice, dipped in deionized water
and left to dry overnight. Fixation was performed in
methanol for 5 min. The slides were stained with ethidium
bromide and scored using a fluorescence microscope
(Leica DMLB, Houston, TX) with Comet assay III software(Perceptive Instruments, Suffolk, UK). At least 50 cells
were scored per sample and the results were expressed as
mean percent DNA in tail. Hydrogen peroxide (25 μM)
for 10 min was used a positive control. Experiments were
performed at least three individual times.
Immunofluorescence staining for γH2AX foci
γH2AX foci formation is a well-established molecular
marker for DNA damage and repair. At the site of DNA
double strand breaks, H2AX is phosphorylated at the
Ser-139 residue promoting recruitment and accumula-
tion of DNA damage response proteins [57]. BEAS-2B
cells were seeded in 24 well plates on coverslips and ex-
posed to 10 μg/mL AgNPs dispersion for 24 h. Etoposide
(5 μM) was used as a positive control. After exposure, cells
were fixed in 4% formaldehyde for 30 min at room
temperature, followed by permeabilisation with 0.25% Tri-
ton X-100 and blocking in 3% bovine serum albumin solu-
tion. Cells were incubated with an anti-phospho-histone
H2AX (Ser139) FITC conjugated antibody (Millipore™,
3 μg/mL) for 1 h and the coverslips were mounted with
DAPI containing mounting medium. Images were ac-
quired using a confocal laser scanning microscope
(Zeiss Confocal Microscope LSM510 META) operating
with LSM 5 series software. The experiments were re-
peated three times.
Ag release in cell medium
The release of Ag in cell medium was determined by
means of AAS. 10 μg/mL AgNPs dispersions were pre-
pared in complete cell medium (BEGM) and kept at
37°C. After 4 and 24 h samples were centrifuged (1 h,
15 000 rpm, 0°C) and the supernatant was collected.
The total Ag concentration in solution was determined
using AAS in the graphite furnace mode (Perkin Elmer
Analyst 800) as described in the quantification of cellu-
lar dose section. The Ag release was also measured in
ALF (artificial lysosomal fluid). The artificial lysosomal fluid
has a pH of 4.5 and is intended to mimic the lysosomal
acidic environment. ALF composition in g/L follows: MgCl2
0.050, NaCl 3.21, Na2HPO4 0.071, Na2SO4 0.039, CaCl2 ·
2H2O 0.128, C6H5Na3O7 · 2H2O 0.077, NaOH 6.00,
C6H8O7 20.8, H2NCH2COOH 0.059, C4H4O6Na2 · 2H2O
0.090, C3H5NaO3 0.085, C3H3O3Na 0.086 [58,59].
10 μg/mL AgNPs dispersions were prepared in ALF and
kept at 37°C. After 4 and 24 h samples were centrifuged
(1 h, 15 000 rpm, 0°C), the supernatant was collected
and analyzed by AAS according to the previously men-
tioned protocol.
Statistical analysis
Data was analyzed in GraphPad Prism (version 5.02)
by one-way or two-way analysis of variance (ANOVA)
followed by Dunnett’s multiple comparison and Bonferroni
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sidered statistically significant. The error bars represent
standard deviation of the mean.
Additional files
Additional file 1: Table S1. The particle size distribution in cell
medium (BEGM) by volume and the scattered light intensity determined
by PCCS. The particle size distribution by volume corresponds to 10%
(d0.1), 50% (d0.5) and 90% (d0.9) and the scattered light intensity of the
measurement depends on the size and concentration of the particles in
solution.
Additional file 2: Figure S1. Cell viability of BEAS-2B cells after 4 h
exposure to AgNPs. Cell viability of BEAS-2B cells after 4 h exposure to
AgNPs (5–50 μg/mL) was assessed using AB assay (A) and LDH assay (B).
Results are presented as mean ± standard deviation of 3 independent
experiments.
Additional file 3: Figure S2. Interference of AgNPs with the Alamar
Blue assay. Different concentrations (5–50 μg/mL) of AgNPs dispersions in
BEGM cell medium were incubated with the AB reagent for 2 h at
37°C in 96 well plates and fluorescence was recorded (Ex560/Em590). A
cellular system with 80% confluent BEAS-2B cells was used as a reference.
For all the AgNPs there was a slight dose dependent increase in
fluorescence (Ex560/Em590). However this increase is not significant
when compared to the cellular systems (25 fold higher) and is unlikely to
interfere with the results. Figure S3. Interference of AgNPs with the LDH
assay. BEAS-2B cells were seeded in 96 well plates and lysed the following
day with he the same lysis agent as in the LDH protocol. The lysate was
incubated with AgNPs (5 μg/mL and 20 μg/mL) for 0, 4 and 24 h before
performing the LDH assay. The results show that the enzyme activity
decreased over time for all samples. At timepoint 0 there was no major
difference between samples with no signs of LDH enzyme inhibition.
After 4 h incubation there was a decrease in enzyme activity for the
10 nm AgNPs and also for the 75 nm AgNPs at the highest concentration
(20 μg/mL). After 24 h, a dose dependent decrease in LDH activity was
observed for the 10 nm AgNPs, especially for the citrate coated ones,
and to some extent also for the 40 nm coated particles at the highest
dose.
Additional file 4: Figure S4. ROS levels in BEAS-2B cells during 4 h
exposure to AgNPs. ROS formation after exposure to AgNPs was
investigated using the DCFH-DA assay. Cells were incubated with AgNPs
(5, 10, 20 μg/mL) or tert-butyl hydroperoxide (TBP, 200 μM, positive
control) for 4 h with readings (excitation 485 nm, emission 535 nm)
performed every 30 min. ROS induction was expressed as mean slope
per hour and normalized to the unexposed control. Results are presented
as mean ± standard deviation of 3 independent experiments.
Additional file 5: Figure S5. TEM images of BEAS-2B cells after 4 h
exposure to AgNPs. TEM images of untreated BEAS-2B cells showed no
morphological changes (A, a). After 4 h exposure to 10 μg/mL 10 nm
citrate coated (B, b), 10 nm PVP coated (C, c), 40 nm citrate coated
(D, d), 75 nm citrate coated (E, e) and 50 nm uncoated (F, f) AgNPs,
there was clear particle localization within endo-lysosomal vesicles
(black arrows).
Additional file 6: Figure S6. Ag release in artificial lysosomal fluid
(ALF). The amount of Ag release in ALF solution over 4 and 24 h at 37°C
was quantified by means of AAS and expressed as the percentage of the
total amount of added Ag (10 μg/mL). The overall amount of Ag
released and measured in solution was very low (less than 2%),
considerably lower than the release in cell medium. This was likely
related to increased agglomeration together with complexation and
sedimentation of silver species (such as AgCl) followed by removal upon
particle separation.
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